Involvement of the JNK signaling in granular corneal dystrophy by modulating TGF-β-induced TGFBI expression and corneal fibroblast apoptosis

In Vitro Cell Dev Biol Anim. 2020 Mar;56(3):234-242. doi: 10.1007/s11626-019-00424-6. Epub 2020 Mar 18.

Abstract

Granular corneal dystrophy (GCD) is featured by corneal deposits of transforming growth factor beta-induced gene (TGFBI) mediated by the TGF-β (transforming growth factor-β)/Smad signaling. However, the roles of c-Jun amino-terminal kinase (JNK) pathway in GCD pathogenesis remains unexplored, which was investigated in this study. JNK signaling activation and inhibition in primary corneal fibroblasts were obtained by treatments with anisomycin and SP600125, respectively. Protein abundance and phosphorylation were detected by immunoblotting. Cell viability and apoptosis were analyzed by CCK-8 and flow cytometry respectively. TGFBI deposit and autophagy progression were assessed by immunofluorescence. The results found that JNK1 expression and phosphorylation were greatly increased in corneal tissues from GCD2 patients. JNK signaling activation impaired the viability and promoted apoptosis and autophagy processes in primary corneal fibroblasts, along with Smad2/3 phosphorylation, TGFBI accumulation and Bcl-2 suppression. Autophagy related proteins, such as ATG5 (autophagy related 5), ATG12 (autophagy related 12) and LC3B (microtubule-associated protein 1 light chain 3 beta), were also increased in anisomycin or TGF-β1 treated corneal fibroblasts. However, SP600125 effectively reversed the above effect induced by TGF-β1 treatment in corneal fibroblasts, including the TGF-β-induced autophagy progression. The results suggested that JNK signaling was activated in GCD2 corneal tissues, and it mediated the TGF-β-induced TGFBI protein accumulation and apoptosis of corneal fibroblasts during GCD2 pathogenesis.

Keywords: Apoptosis; Corneal fibroblasts; Granular corneal dystrophy; JNK signaling; TGF-β.

MeSH terms

  • Apoptosis* / drug effects
  • Autophagy
  • Cornea / pathology*
  • Corneal Dystrophies, Hereditary / enzymology*
  • Corneal Dystrophies, Hereditary / pathology*
  • Extracellular Matrix Proteins / metabolism*
  • Fibroblasts / metabolism
  • Fibroblasts / pathology*
  • Humans
  • MAP Kinase Signaling System* / drug effects
  • Smad Proteins / metabolism
  • Transforming Growth Factor beta / metabolism
  • Transforming Growth Factor beta / pharmacology*

Substances

  • Extracellular Matrix Proteins
  • Smad Proteins
  • Transforming Growth Factor beta
  • betaIG-H3 protein